Showing posts with label Slovenia. Show all posts
Showing posts with label Slovenia. Show all posts

Browse the complete Report on : Slovenia Food and Drink Report Q4 2010
Browse All Business Monitor International Market Research Reports
Slovenia is a mature food and drink market, with a well-developed mass grocery retail (MGR) infrastructure. As such, the longer-term returns on investment will remain subdued in potential, while the immediate operating environment will continue to suffer the fall-out of the economic crisis, both in terms of volumes and values, although the Slovenian consumer has not been as severely impacted as some of its emerging Europe peers. Generally speaking, high per capita incomes will continue to ensure some room for growth of premium goods, which will remain well-supported by concerted marketing and advertising campaigns. To this end, although major multinationals will largely sideline Slovenia, key regional players will continue to show interest in the market, both directly and through acquisitions.
Headline Industry Data
  • 2010 per capita food consumption: -0.39%; forecast to 2014: +6.29%
  • 2010 alcoholic drinks sales: -0.65%; forecast to 2014: +16.91%
  • 2010 soft drinks sales: +1.09%; forecast to 2014: +11.01%
  • 2010 mass grocery retail sales: +2.42%; forecast to 2014: +28.06%
Key Company Trends
Regional Consolidation in Food and Drinks – In July 2010, in what is poised to be one of emerging
Europe’s biggest food and drink deals of the past months, the Croatian functional food and drink producer and distributor Atlantic Grupa reached an agreement to acquire the Slovenian food company Droga Kolinska. The deal should significantly strengthen Atlantic’s competitive position in the Balkans and make it one of the region’s largest food and drink firms by annual sales (reportedly, of close to US$900mn, if the deal is closed). For its part, Droga’s flagging performance has the potential to be revitalised, especially as it manufactures a number of brand s– including Cockta and Grand Kafa – which generate over EUR10mn in annual sales.
Key Risks to Outlook
The Underperforming Economy – One of the fall-outs from the Greece’s financial crisis is an increased level of attention paid to other EU members’ finances. The Slovenian government has already cut its 2010 state expenditure by EUR500mn, which will – among other measures – be achieved through public sector wage cuts and restrictions on student employment. In addition to high unemployment rates, the situation provides little room for optimism in regards to consumer spending during the year, potentially dampening the forecast food and beverages volume and value growth. On a large scale, as a small and heavily tradeand investment-integrated economy with Western Europe, the performance in the Slovenian economy will remain hampered beyond 2010 by protracted weak demand from the eurozone, as well as by lower levels of marketing and investment ploughed into Slovenia by EU companies.
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Read More




In BMI’s Business Environment Ratings (BERs) table for Q410, Slovenia is ranked ninth of the 20 markets assessed in CEE, up by one place in relation to the previous quarter. Overall, Slovenia’s attractiveness suffers from a small market size and low forecast growth, although the high per-capita GDP and widespread health awareness play in favour of pharmaceutical companies.
In addition to a EUR49mn (US$61mn) reduction in its healthcare budget in early June 2010, the Slovenian Ministry of Health has now proposed a series of pharmaceutical cost-containment measures. These developments will impact sales and increase price competition in the country's drug market. Efforts to contain publicly-funded pharmaceutical costs in Slovenia are not dissimilar to the actions of other European states to limit healthcare expenditure and generally cut their budgets. Slovenia's continuing economic difficulties are significant, but not disproportionate to the rest of Europe, with nominal GDP growth of -6% in 2009 and a government budget deficit of EUR1.8bn (US$2.25bn), almost 5% of GDP.
With public sector healthcare spending representing 74% of the total healthcare market, any reduction in government funding will have a significant impact on the rest of the market. However, Slovenia's welldeveloped system of prescription co-payments for more expensive drugs means that introducing private payments will reduce the impact of the healthcare cuts and cost-containment measures. Though the cost-containment measures are not price erosion mechanisms like those seen in Greece, Portugal and Spain, the intention of the proposed measures align with BMI's short-term core view that government price erosion mechanisms will accelerate across Europe. In recent years, drug expenditure has risen steadily in Slovenia, with a compound annual growth rate (CAGR) of 6.3% in local currency terms and 5.72% in US dollar terms between 2004 and 2009. BMI forecasts that between 2009 and 2014 the drug market will experience a CAGR of just 3.76% in local currency terms and 3.27% in US dollar terms, to reach a value of EUR653mn (US$816mn) in 2014, up from EUR543mn (US$695mn) in 2009.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004

Read More

Browse the complete Report on : Slovenia Pharmaceuticals and Healthcare Report Q4 2010

Browse All Business Monitor International Market Research Reports


In BMI’s Business Environment Ratings (BERs) table for Q410, Slovenia is ranked ninth of the 20 markets assessed in CEE, up by one place in relation to the previous quarter. Overall, Slovenia’s attractiveness suffers from a small market size and low forecast growth, although the high per-capita GDP and widespread health awareness play in favour of pharmaceutical companies.
In addition to a EUR49mn (US$61mn) reduction in its healthcare budget in early June 2010, the Slovenian Ministry of Health has now proposed a series of pharmaceutical cost-containment measures. These developments will impact sales and increase price competition in the country's drug market. Efforts to contain publicly-funded pharmaceutical costs in Slovenia are not dissimilar to the actions of other European states to limit healthcare expenditure and generally cut their budgets. Slovenia's continuing economic difficulties are significant, but not disproportionate to the rest of Europe, with nominal GDP growth of -6% in 2009 and a government budget deficit of EUR1.8bn (US$2.25bn), almost 5% of GDP.
With public sector healthcare spending representing 74% of the total healthcare market, any reduction in government funding will have a significant impact on the rest of the market. However, Slovenia's welldeveloped system of prescription co-payments for more expensive drugs means that introducing private payments will reduce the impact of the healthcare cuts and cost-containment measures. Though the cost-containment measures are not price erosion mechanisms like those seen in Greece, Portugal and Spain, the intention of the proposed measures align with BMI's short-term core view that government price erosion mechanisms will accelerate across Europe. In recent years, drug expenditure has risen steadily in Slovenia, with a compound annual growth rate (CAGR) of 6.3% in local currency terms and 5.72% in US dollar terms between 2004 and 2009. BMI forecasts that between 2009 and 2014 the drug market will experience a CAGR of just 3.76% in local currency terms and 3.27% in US dollar terms, to reach a value of EUR653mn (US$816mn) in 2014, up from EUR543mn (US$695mn) in 2009.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.


Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Read More

Browse the complete Report on: Slovenia Food and Drink Report Q4 2010

Browse All Business Monitor International Market Research Reports

Slovenia is a mature food and drink market, with a well-developed mass grocery retail (MGR) infrastructure. As such, the longer-term returns on investment will remain subdued in potential, while the immediate operating environment will continue to suffer the fall-out of the economic crisis, both in terms of volumes and values, although the Slovenian consumer has not been as severely impacted as some of its emerging Europe peers. Generally speaking, high per capita incomes will continue to ensure some room for growth of premium goods, which will remain well-supported by concerted marketing and advertising campaigns. To this end, although major multinationals will largely sideline Slovenia, key regional players will continue to show interest in the market, both directly and through acquisitions.
Headline Industry Data
  • 2010 per capita food consumption: -0.39%; forecast to 2014: +6.29%
  • 2010 alcoholic drinks sales: -0.65%; forecast to 2014: +16.91%
  • 2010 soft drinks sales: +1.09%; forecast to 2014: +11.01%
  • 2010 mass grocery retail sales: +2.42%; forecast to 2014: +28.06%
Key Company Trends
Regional Consolidation in Food and Drinks – In July 2010, in what is poised to be one of emerging
Europe’s biggest food and drink deals of the past months, the Croatian functional food and drink producer and distributor Atlantic Grupa reached an agreement to acquire the Slovenian food company Droga Kolinska. The deal should significantly strengthen Atlantic’s competitive position in the Balkans and make it one of the region’s largest food and drink firms by annual sales (reportedly, of close to US$900mn, if the deal is closed). For its part, Droga’s flagging performance has the potential to be revitalised, especially as it manufactures a number of brand s– including Cockta and Grand Kafa – which generate over EUR10mn in annual sales.
Key Risks to Outlook
The Underperforming Economy – One of the fall-outs from the Greece’s financial crisis is an increased level of attention paid to other EU members’ finances. The Slovenian government has already cut its 2010 state expenditure by EUR500mn, which will – among other measures – be achieved through public sector wage cuts and restrictions on student employment. In addition to high unemployment rates, the situation provides little room for optimism in regards to consumer spending during the year, potentially dampening the forecast food and beverages volume and value growth. On a large scale, as a small and heavily tradeand investment-integrated economy with Western Europe, the performance in the Slovenian economy will remain hampered beyond 2010 by protracted weak demand from the eurozone, as well as by lower levels of marketing and investment ploughed into Slovenia by EU companies.
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Read More

Browse the complete Report on: Slovenia Pharmaceuticals and Healthcare Report Q4 2010

Browse All Business Monitor International Market Research Reports

In BMI’s Business Environment Ratings (BERs) table for Q410, Slovenia is ranked ninth of the 20 markets assessed in CEE, up by one place in relation to the previous quarter. Overall, Slovenia’s attractiveness suffers from a small market size and low forecast growth, although the high per-capita GDP and widespread health awareness play in favour of pharmaceutical companies.
In addition to a EUR49mn (US$61mn) reduction in its healthcare budget in early June 2010, the Slovenian Ministry of Health has now proposed a series of pharmaceutical cost-containment measures. These developments will impact sales and increase price competition in the country's drug market. Efforts to contain publicly-funded pharmaceutical costs in Slovenia are not dissimilar to the actions of other European states to limit healthcare expenditure and generally cut their budgets. Slovenia's continuing economic difficulties are significant, but not disproportionate to the rest of Europe, with nominal GDP growth of -6% in 2009 and a government budget deficit of EUR1.8bn (US$2.25bn), almost 5% of GDP.
With public sector healthcare spending representing 74% of the total healthcare market, any reduction in government funding will have a significant impact on the rest of the market. However, Slovenia's welldeveloped system of prescription co-payments for more expensive drugs means that introducing private payments will reduce the impact of the healthcare cuts and cost-containment measures. Though the cost-containment measures are not price erosion mechanisms like those seen in Greece, Portugal and Spain, the intention of the proposed measures align with BMI's short-term core view that government price erosion mechanisms will accelerate across Europe. In recent years, drug expenditure has risen steadily in Slovenia, with a compound annual growth rate (CAGR) of 6.3% in local currency terms and 5.72% in US dollar terms between 2004 and 2009. BMI forecasts that between 2009 and 2014 the drug market will experience a CAGR of just 3.76% in local currency terms and 3.27% in US dollar terms, to reach a value of EUR653mn (US$816mn) in 2014, up from EUR543mn (US$695mn) in 2009.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Read More

Browse the complete Report on: Slovenia Insurance Report Q4 2010


Writing at the beginning of August 2010, we have been able to ensure that the report includes actual data for 2009. According to the Slovenian Insurance Assocation (Slovensko Zavarovalno ZdruĹženje, SZZ), total premiums in 2009 amounted to EUR2.08bn. This includes non-life premiums of EUR1.45bn and life premiums of EUR630mn. In 2014, the corresponding figures should be EUR2.70bn, EUR1.95bn and EUR747mn. In terms of the key drivers that underpin our forecasts, we are looking for non-life penetration to remain constant at around 4.4% of GDP. We are looking for life density to rise marginally from US$444 to US$450 per capita. BMI's proprietary Insurance Business Environment Rating (IBER) for Slovenia is 58.4 out of 100.
Slovenia’s Insurance Sector In 2010
Slovenia’s insurance sector was one of the strongest and most stable in Central and Eastern Europe in 2009. Figures from the SZZ indicated that in the first nine months of 2009 non-life premiums rose 5% to EUR1,124mn, and life premiums fell 4% to EUR467mn. It is fair to say that the non-life segment is among the fastest growing in the region and the life segment has escaped the trauma suffered by its peers elsewhere. Only Turkey, where life insurance is developing rapidly as a result of lower overall levels of financial risk, Croatia and the Czech Republic, where life premiums grew by 3-4% in H109, outperformed Slovenia in growth.
Slovenia’s well-developed life segment is unusual in a Central and Eastern European context, in that it is dominated by unit-linked products, which accounted for EUR279mn out of the EUR467mn in life premiums written in the first nine months of 2009. Impressively, given the volatility in financial markets in 2008, unit-linked premiums remained virtually unchanged.
Of the non-life lines, compulsory motor third party liability (CMTPL) stood out for the fall in gross premiums, from EUR277mn in the first three quarters of 2008 to EUR256mn in the same period of 2009. In most other non-life lines premiums increased, in some instances by a significant amount. Health insurance premiums grew from EUR290mn to EUR311mn. CASCO rose from EUR170mn to EUR189mn.
The SZZ’s figures for 2009 indicate that there have been only minor changes to market shares. In the nonlife segment, the share of former state-owned monopoly Triglav fell slightly, to 37%, while that of Maribor slipped to just over 14%. The shares of Adriatic Slovenica and Vzajemna rose slightly, to about 17%. Triglav and Maribor appear to have lost ground slightly in the life sector too (where they had 34% and 11% of gross premiums respectively).
On the basis of the figures published by the SZZ in relation to the first five months of 2010, we are currently looking for non-life premiums to track sideways this year. Life premiums appear set for another year of contraction: we envisage that they will diminish by 8%. Nevertheless, it seems reasonable to expect that both segments will return to a trend of modest growth from 2011. Relative to Q310, Slovenia’s IBER has fallen slightly. This is because the anticipated absolute growth of the sector is less than we had previously been forecasting.
Issues To Watch
Pricing In The CMTPL Line
The divergent directions of premiums in CMTPL and CASCO lines across much of 2009 suggest there may be strong downwards pressure in the former.
Continuing Growth In Unit-Linked Insurance
The development of unit-linked products has been key in underpinning life segment stability in recent months.
Further Expansion Of Slovenian Insurers Into Other Markets In Central And Eastern Europe
Slovenia now has most of the characteristics of a fully developed insurance market.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004



Read More